Lineage Cell Therapeutics, Inc. Increase (Decrease) in Other Noncurrent Liabilities
Lineage Cell Therapeutics, Inc. (LCTX) reported Increase (Decrease) in Other Noncurrent Liabilities of -$56.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2017-03-16
- Lineage Cell Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2016-12-31 was -$89.00K.
- Lineage Cell Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2016-09-30 was $117.00K.
- Lineage Cell Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2016-06-30 was -$78.00K.
- Lineage Cell Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2016-03-31 was -$6.00K, a 154.55% decline year-over-year.
- Lineage Cell Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2016 was -$56.00K.
- Lineage Cell Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2015 was -$20.00K.
- Lineage Cell Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2014 was -$160.00K.
- Lineage Cell Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2013 was -$58.00K.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 3 month as first filed | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month as first filed | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month as first filed | Increase (Decrease) in Other Noncurrent Liabilities 12 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | -$89.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $28.00K derived: sum of 2 quarters · filed 2017-03-16 | -$50.00K derived: sum of 3 quarters · filed 2017-03-16 | -$56.00K 10-K · filed 2017-03-16 | ||||
| 2016-09-30 | $117.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $39.00K derived: sum of 2 quarters · filed 2016-11-04 | $33.00K 10-Q · filed 2016-11-04 | $22.00K derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2016-06-30 | -$78.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$84.00K 10-Q · filed 2016-08-09 | -$95.00K derived: sum of 3 quarters · filed 2017-03-16 | -$104.00K derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2016-03-31 | -$6.00K 10-Q · filed 2016-05-10 | -$17.00K derived: sum of 2 quarters · filed 2017-03-16 | -$26.00K derived: sum of 3 quarters · filed 2017-03-16 | -$37.00K derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-12-31 | -$11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$20.00K derived: sum of 2 quarters · filed 2017-03-16 | -$31.00K derived: sum of 3 quarters · filed 2017-03-16 | -$20.00K 10-K · filed 2017-03-16 | ||||
| 2015-09-30 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | -$20.00K derived: sum of 2 quarters · filed 2016-11-04 | -$9.00K 10-Q · filed 2016-11-04 | -$45.00K derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-06-30 | -$11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $0.00 10-Q · filed 2016-08-09 | $1.00K 10-Q · filed 2015-08-10 | -$36.00K derived: sum of 3 quarters · filed 2017-03-16 | $26.00K derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-03-31 | $11.00K 10-Q · filed 2016-05-10 | $10.73K 10-Q · filed 2015-05-08 | -$25.00K derived: sum of 2 quarters · filed 2017-03-16 | $37.00K derived: sum of 3 quarters · filed 2017-03-16 | $36.72K derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2014-12-31 | -$36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $26.00K derived: sum of 2 quarters · filed 2017-03-16 | $25.72K derived: sum of 3 quarters · filed 2017-03-16 | -$160.00K 10-K · filed 2017-03-16 | -$160.25K 10-K · filed 2015-03-11 | |||
| 2014-09-30 | $62.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $61.72K derived: sum of 2 quarters · filed 2015-11-09 | -$124.00K 10-Q · filed 2015-11-09 | -$124.44K 10-Q · filed 2014-11-07 | -$133.68K derived: sum of 4 quarters · filed 2016-03-15 | |||
| 2014-06-30 | -$283.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$186.00K 10-Q · filed 2015-08-10 | -$186.39K 10-Q · filed 2014-08-11 | -$195.68K derived: sum of 3 quarters · filed 2016-03-15 | -$202.27K derived: sum of 4 quarters · filed 2016-03-15 | |||
| 2014-03-31 | -$185.72K 10-Q · filed 2015-05-08 | -$195.40K derived: sum of 2 quarters · filed 2016-03-15 | -$201.99K derived: sum of 3 quarters · filed 2016-03-15 | -$235.91K derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2013-12-31 | -$9.68K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | -$16.27K derived: sum of 2 quarters · filed 2016-03-15 | -$50.19K derived: sum of 3 quarters · filed 2016-03-15 | -$58.00K 10-K · filed 2016-03-15 | -$57.82K 10-K · filed 2014-03-17 | |||
| 2013-09-30 | -$6.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$40.52K derived: sum of 2 quarters · filed 2014-11-07 | -$48.32K 10-Q · filed 2014-11-07 | -$57.72K derived: sum of 4 quarters · filed 2015-03-11 | ||||
| 2013-06-30 | -$33.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$41.73K 10-Q · filed 2014-08-11 | -$51.13K derived: sum of 3 quarters · filed 2015-03-11 | -$54.36K derived: sum of 4 quarters · filed 2015-03-11 | ||||
| 2013-03-31 | -$7.81K 10-Q · filed 2014-05-12 | -$17.21K derived: sum of 2 quarters · filed 2015-03-11 | -$20.43K derived: sum of 3 quarters · filed 2015-03-11 | -$24.13K derived: sum of 4 quarters · filed 2015-03-11 | ||||
| 2012-12-31 | -$9.40K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | -$12.63K derived: sum of 2 quarters · filed 2015-03-11 | -$16.32K derived: sum of 3 quarters · filed 2015-03-11 | -$26.09K 10-K · filed 2015-03-11 | ||||
| 2012-09-30 | -$3.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$6.92K derived: sum of 2 quarters · filed 2013-11-12 | -$16.69K 10-Q · filed 2013-11-12 | -$24.58K derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2012-06-30 | -$3.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$13.46K 10-Q · filed 2013-08-09 | -$21.35K derived: sum of 3 quarters · filed 2014-03-17 | -$20.30K derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2012-03-31 | -$9.76K 10-Q · filed 2013-05-10 | -$17.66K derived: sum of 2 quarters · filed 2014-03-17 | -$16.60K derived: sum of 3 quarters · filed 2014-03-17 | -$43.83K derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2011-12-31 | -$7.89K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | -$6.84K derived: sum of 2 quarters · filed 2014-03-17 | -$34.07K derived: sum of 3 quarters · filed 2014-03-17 | -$39.63K 10-K · filed 2014-03-17 | ||||
| 2011-09-30 | $1.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$26.18K derived: sum of 2 quarters · filed 2012-11-09 | -$31.74K 10-Q · filed 2012-11-09 | -$31.74K derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2011-06-30 | -$27.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$32.80K 10-Q · filed 2012-08-09 | -$32.80K derived: sum of 3 quarters · filed 2013-03-18 | -$32.80K derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2011-03-31 | -$5.56K 10-Q · filed 2012-05-10 | -$5.56K derived: sum of 2 quarters · filed 2013-03-18 | -$5.56K derived: sum of 3 quarters · filed 2013-03-18 | |||||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $0.00 derived: sum of 2 quarters · filed 2013-03-18 | $0.00 10-K · filed 2013-03-18 | |||||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $0.00 10-Q · filed 2011-11-08 | ||||||
| 2010-06-30 | $0.00 10-Q · filed 2011-08-09 | |||||||
| 2009-12-31 | $0.00 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |